Researchers at the Indira Gandhi Agricultural University in Raipur, Chhattisgarh, have discovered that a rare variety of rice from the Bastar region, known as ‘Sanjeevani,’ possesses properties that can eliminate cancer cells. This rice, which is on the verge of extinction, has shown promising results in laboratory tests. Collaborating with the Bhabha Atomic Research Centre, scientists found that Sanjeevani rice contains compounds that combat cancer. Animal trials on mice yielded positive outcomes, and the Central Drug Research Institute has also confirmed the cancer-fighting capabilities of this rice. Human trials are scheduled to begin in January at the Tata Memorial Cancer Hospital. Sanjeevani rice contains 213 biochemicals, including seven compounds known for their anti-cancer effects. It is believed that these compounds activate the NRF2 pathway, which acts as an antioxidant, protecting the body from oxidative damage that can lead to cancer. Consumption of 10 grams of Sanjeevani rice daily for ten days is recommended to boost immunity and potentially prevent the formation of tumors. This rice could become the first of its kind to be used medicinally, with potential applications within the next two to three years. Dr. Deepak Sharma emphasizes that this discovery aligns with the vision of Dr. R. H. Richharia, who predicted the future of rice therapy decades ago.
